Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Marketable Securities : ₹1,176 Mil (As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Jagsonpal Pharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Jagsonpal Pharmaceuticals's Marketable Securities for the quarter that ended in Mar. 2025 was ₹1,176 Mil.

Jagsonpal Pharmaceuticals's annual Marketable Securities increased from Mar. 2023 (₹1,037 Mil) to Mar. 2024 (₹1,352 Mil) but then declined from Mar. 2024 (₹1,352 Mil) to Mar. 2025 (₹1,176 Mil).

Jagsonpal Pharmaceuticals Marketable Securities Historical Data

The historical data trend for Jagsonpal Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jagsonpal Pharmaceuticals Marketable Securities Chart

Jagsonpal Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Marketable Securities

Get a 7-Day Free Trial

52.31

248.75

1,036.58

1,351.74

1,175.84

Jagsonpal Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Marketable Securities	Get a 7-Day Free Trial															1,351.74	-	595.14	-	1,175.84

Jagsonpal Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Jagsonpal Pharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of Jagsonpal Pharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jagsonpal Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jagsonpal Pharmaceuticals Ltd (NSE:JAGSNPHARM) » Definitions » Marketable Securities

Traded in Other Exchanges

507789:India

Address

3rd Floor, Phase – IV, Udyog Vihar, Plot No. 412-415, Nimai Tower, Gurugram, HR, IND, 122015

Website

https://www.jagsonpal.com

Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company operates in the Gynaecology, Orthopaedics, Dermatology and Paediatric segments. Its brands comprise Lycored, Maintane, Metadec, Metabol, Doxypal DR, and others.

Jagsonpal Pharmaceuticals Headlines

No Headlines